Related Experiment Video
Updated: Aug 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Proteomics of TGF-beta signaling and its impact on breast cancer
1Uppsala University, Ludwig Institute for Cancer Research, Box 595, SE-75124, Uppsala, Sweden. serhiy.souchelnytskyi@licr.uu.se
Abstract:
The complexity of mechanisms leading to the appearance and progression of cancer is a challenge being addressed by large-scale studies, such as proteomics. Simultaneous monitoring of thousands of proteins uncovers novel signaling mechanisms, thus revising our knowledge of tumorigenesis. Transforming growth factor (TGF)-beta is a secreted polypeptide that is known to inhibit tumor growth at the early stages of cancer, but promote metastasis at the later stages. Proteomics-based studies have significantly widened our knowledge of TGF-beta-dependent regulation of cell proliferation, apoptosis, DNA damage repair and transcription. This leads to better understanding of the TGF-beta role in human breast tumorigenesis, and opens the way for the development of novel anticancer treatments and drugs, with some of the drugs already entering clinics. This review discusses recent advances in proteomics studies of TGF-beta signaling and its contribution to the understanding and treatment of breast cancer.
Insights
Large-scale proteomics studies reveal complex cancer mechanisms. Understanding transforming growth factor-beta (TGF-beta) signaling in breast cancer advances novel therapeutic strategies.
Area of Science:
- Oncology and Molecular Biology
- Proteomics and Cancer Signaling
Background:
- Cancer progression involves complex molecular mechanisms, necessitating large-scale studies like proteomics.
- Transforming growth factor-beta (TGF-beta) exhibits dual roles in cancer, inhibiting early tumor growth but promoting later-stage metastasis.
Purpose of the Study:
- To review recent advances in proteomics studies of TGF-beta signaling in breast cancer.
- To elucidate the contribution of TGF-beta signaling to breast tumorigenesis and treatment.
Main Methods:
- Utilizing proteomics to monitor thousands of proteins simultaneously.
- Analyzing TGF-beta-dependent regulation of key cellular processes including proliferation, apoptosis, DNA repair, and transcription.
Main Results:
- Proteomics has significantly expanded the understanding of TGF-beta's role in breast cancer.
- Identified novel signaling mechanisms contributing to tumorigenesis.
Conclusions:
- Enhanced understanding of TGF-beta signaling pathways in breast cancer.
- Opens avenues for developing novel anticancer treatments and drugs targeting TGF-beta pathways.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

